ABCDFGHIJKL
1
TopicsArticle TitleAuthorLevel of EvidenceSummaryLimitationsWhat are Experts Saying?RecommendationsLink to the articleDate Published
2
Treatment Guidelines
3
Remdesivir for the Treatment of Covid-19 — Preliminary ReportBeigel, et. al1b
(Individual randomized controlled trials (with narrow
confidence intervals))		- Double-blinded, randomized control study
- Stopped early because improved recovery time, from 15 days. Increased survival.
- Has promise, but needs more research.		Promising, but signficant limitations.
Governmental study.
Used multiple outcomes and compared p-values, as opposed to picking an outcome that is predetermined.
Unclear if clinical significance.		Remdesivir has promising results, but more research needed to determine clinical significance.https://www.nejm.org/doi/full/10.1056/NEJMoa20077645/22/2020
4
Provider Interests
5
6
Public Health Concerns
7
8
Diagnostics
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100